Skip to main content
. 2022 Jul 2;11:132–145. doi: 10.1016/j.xjon.2022.06.019

Table 1.

Model parameters

Variable Value Reference
Cost
 Transplant
 Inpatient costs for ECMO-bridged transplant $636,023 Patient-level data
 Inpatient costs for non–ECMO-bridged transplant $538,928 Patient-level data
 LVAD
 Inpatient costs for ECMO-bridged LVAD $769,471 Patient-level data
 Inpatient costs for non–ECMO-bridged LVAD $325,242 Patient-level data
 Annual cost after transplant
 Year 1 $155,512 Long and colleagues, 201412
 Year 2 and beyond $34,905 Long and colleagues, 201412
 Annual cost after LVAD
 Year 1 $164,831 Long and colleagues, 201412
 Year 2 and beyond $46,835 Long and colleagues, 201412
 End-of-life care costs $62,324 Long and colleagues, 201412
QALY weights
 Postheart transplant
 NYHA I  0.90 Göhler and colleagues, 200913
 NYHA II  0.83 Göhler and colleagues, 200913
 NYHA III  0.74 Göhler and colleagues, 200913
 NYHA IV  0.60 Göhler and colleagues, 200913
 Post-LVAD
 ECMO-bridged QALY  0.82 Unai and colleagues, 201714
 Non–ECMO-bridged QALY  0.79 Unai and colleagues, 201714
Survival
 Years after transplant
 ECMO-bridged survival
 1 Year  0.707 DeFilippis and colleagues, 202115
 2 Year  0.666 DeFilippis and colleagues, 202115
 5 Year  0.618 DeFilippis and colleagues, 202115
 Non–ECMO-bridged survival
 1 Year  0.92 Mishra and colleagues, 201716
 3 Year  0.87 Mishra and colleagues, 201716
 5 Year  0.81 Mishra and colleagues, 201716
 7 Year  0.77 Mishra and colleagues, 201716
 Years after LVAD placement
 ECMO-bridged survival
 1 Year  0.692 DeFilippis and colleagues, 202115
 2 Year  0.626 DeFilippis and colleagues, 202115
 5 Year  0.565 DeFilippis and colleagues, 202115
 Non–ECMO-bridged survival
 1 Year  0.88 Han and colleagues, 201817

ECMO, Extracorporeal membranous oxygenation; LVAD, left ventricular assist device; QALY, quality-adjusted life years; NYHA, New York Heart Association.

Cost in 2020 US dollars.